Algert Global’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-99,200
Closed -$2.46M 1121
2025
Q3
$2.46M Buy
99,200
+36,330
+58% +$811K 0.04% 626
2025
Q2
$1.43M Buy
62,870
+54,550
+656% +$1.29M 0.03% 727
2025
Q1
$252K Sell
8,320
-93
-1% -$3.54K 0.01% 1040
2024
Q4
$334K Buy
+8,413
New +$379K 0.01% 974
2024
Q3
Sell
-9,305
Closed -$628K 1158
2024
Q2
$628K Buy
+9,305
New +$650K 0.02% 823
2022
Q2
Sell
-24,460
Closed -$1.6M 1181
2022
Q1
$1.6M Buy
+24,460
New +$1.42M 0.1% 314

Other funds holding ACHC

Algert Global's ACHC Position: Q4 2025 in Review

Algert Global sold out of Acadia Healthcare (ACHC) in Q4 2025, closing a stake of 99,200 shares — an estimated $2.46M sold.

Algert Global first reported a position in ACHC in Q1 2022 and held it in 6 quarters. The position peaked at $2.46M in Q3 2025. 254 funds tracked by Wall St. Rank hold ACHC as of Q4 2025.

  • Algert Global reported no remaining Acadia Healthcare position as of Q4 2025 after selling out during the quarter.
  • Algert Global sold 99,200 Acadia Healthcare shares in Q4 2025, an estimated $2.46M.
  • Algert Global first reported a position in Acadia Healthcare in Q1 2022 and held it in 6 quarters.
  • Algert Global's Acadia Healthcare position peaked at $2.46M in Q3 2025.
  • 254 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2025.

Based on Algert Global's 13F filing for Q4 2025, filed 17 Feb 2026.